LOADING
Comparing Apple Inc (AAPL) and AbbVie Inc (ABBV) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | AAPL | ABBV |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $4.02T | $354.6B |
| P/E Ratio | 34.6 | 84.6 |
| Forward P/E | 31.1 | 14.2 |
| PEG Ratio | 2.40 | 0.47 |
| EPS | $7.89 | $2.37 |
| Revenue Growth (YoY) | 15.7% | 10.0% |
| Profit Margin | 27.0% | 6.9% |
| Return on Equity | 152.0% | 62.3% |
| Dividend Yield | 0.39% | 3.24% |
| Beta | 1.11 | 0.36 |
| 52-Week High | $288.35 | $239.13 |
| 52-Week Low | $192.41 | $171.00 |
| Volume | -- | -- |
Apple Inc is the larger company by market capitalization. Apple Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Apple Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.